Posted On: November 2017
According to statistics, businesses that employ equal numbers of women and men are 15 percent more likely to perform better than competitors with an unbalanced workforce. Also, companies with a more ethnically diverse workforce are 35 percent more likely to perform better than competitors with little diversity in the workplace. Experts said that being open to new ideas is a key component of any company’s success. With diversity, employers have the benefit of a wider array of perspectives that span multiple genders, age groups, ethnic backgrounds and more. Although these statistics sound good, only a few C-level positions are held by women in S&P 500 companies.
Medical technology and practices have been advancing at an incredible rate over the past few decades, and one of the premier breakthroughs in the space is CRISPR. At a high level, CRISPR is a process that allows editing DNA sequences and gene function, which opens up a world of possibilities when it comes to developing new medicine and treatments. However, CRISPR as we know it today is not a perfectly precise tool, as it requires the rewrite of entire subsections of DNA or a genome. A new breakthrough in a joint study by Harvard and MIT has resulted in a new process called base editing, which gives researchers the ability to edit minute portions of DNA. In other words, if a single word needed changing in a paragraph, CRISPR would require rewriting the entire paragraph with one word changed while base editing would allow changing the specific word itself.
Glen Wakeman, co-founder of LaunchPad Holdings LLC., is a globally recognized writer and consultant that has found his passion in nurturing the business ventures of others. Mr. Wakeman brings with him a vast array of experience, knowledge, and expertise to fuel his efforts to help entrepreneurs navigate the most critical stages of their business development.
“Let’s start with money,” says Eric Lefkofsky, in a recent blog post that was published in Crain’s Chicago Business. “We spend about $3 trillion a year on health care in this country,” and “roughly one-third is wasted.” The mission of his latest startup, Tempus, is to do what for healthcare that his other companies have done for marketing, transportation, and consumer goods. “By bringing Big Data (along with machine learning and artificial intelligence) to healthcare,” Mr. Lefkofsky believes, “we can reduce mortalities by well over 50 percent.”